Share Twitter LinkedIn Facebook Email Drs. Charu Aggarwal and Jack West host dynamic GU oncology specialist Dr. Petros Grivas as they discuss how research, mentorship, and teaching have adapted to digital platforms in the wake of the pandemic. Advertisement
FDA Approves Deciphera Vimseltinib / Romvimza for symptomatic tenosynovial giant cell tumor (TGCT) patients Other 2 Mins Read
FDA Approves Mirdametinib: Is this the Breakthrough NF1-PN Patients Have Been Waiting For? Other 3 Mins Read